-
21دورية أكاديمية
المؤلفون: Morgan, Robert D, Clamp, Andrew R, White, Daniel J, Price, Marcus, Burghel, George J, Ryder, W David J, Mahmood, Reem D, Murphy, Alexander D, Hasan, Jurjees, Mitchell, Claire L, Salih, Zena, Wheeler, Chelsey, Buckley, Emma, Truelove, Joanna, King, Georgia, Ainaoui, Yasmina, Bhaskar, Sanjeev S, Shaw, Joseph, Evans, D Gareth R, Kilerci, Bedirhan, Pearce, Simon P, Brady, Gerard, Dive, Caroline, O'Connor, James P B, Wallace, Andrew J, Rothwell, Dominic G, Edmondson, Richard J, Jayson, Gordon C
المصدر: Morgan , R D , Clamp , A R , White , D J , Price , M , Burghel , G J , Ryder , W D J , Mahmood , R D , Murphy , A D , Hasan , J , Mitchell , C L , Salih , Z , Wheeler , C , Buckley , E , Truelove , J , King , G , Ainaoui , Y , Bhaskar , S S , Shaw , J , Evans , D G R , Kilerci , B , Pearce , S P , Brady , ....
مصطلحات موضوعية: Humans, Female, Poly(ADP-ribose) Polymerase Inhibitors/adverse effects, BRCA1 Protein/genetics, BRCA2 Protein/genetics, Ovarian Neoplasms/drug therapy, Carcinoma, Ovarian Epithelial/drug therapy, Antineoplastic Agents/therapeutic use, Phthalazines/adverse effects, Cystadenocarcinoma, Serous/drug therapy, Neoplasm Recurrence, Local/drug therapy
الإتاحة: https://doi.org/10.1158/1078-0432.CCR-22-3282Test
https://research.manchester.ac.uk/en/publications/4fa27fbe-2aeb-44f7-a334-df8de5f6a0d0Test -
22دورية أكاديمية
المؤلفون: van Barele, M., Akdeniz, D., Heemskerk-Gerritsen, B. A. M., Andrieu, N., Noguès, C., van Asperen, C. J., Wevers, M., Ausems, M., de Bock, G. H., Dommering, C. J., Gómez-García, E. B., van Leeuwen, F. E., Mooij, T. M., Easton, D. F., Antoniou, A. C., Evans, D Gareth R, Izatt, L., Tischkowitz, M., Frost, D., Brewer, C., Olah, E., Simard, J., Singer, C. F., Thomassen, M., Kast, K., Rhiem, K., Engel, C., de la Hoya, M., Foretová, L., Jakubowska, A., Jager, A., Sattler, M. G. A., Schmidt, M. K., Hooning, M. J.
المساهمون: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
العلاقة: https://dx.doi.org/10.1093/jnci/djad116Test; van Barele M, Akdeniz D, Heemskerk-Gerritsen BAM, Andrieu N, Noguès C, van Asperen CJ, et al. Contralateral breast cancer risk in irradiated breast cancer patients with a germline-BRCA1/2 pathogenic variant. Journal of the National Cancer Institute. 2023 Jun 27. PubMed PMID: 37369040. Epub 2023/06/27. eng.; http://hdl.handle.net/10541/626389Test; Journal of the National Cancer Institute
-
23دورية أكاديمية
المؤلفون: Kast, K., John, E. M., Hopper, J. L., Andrieu, N., Noguès, C., Mouret-Fourme, E., Lasset, C., Fricker, J. P., Berthet, P., Mari, V., Salle, L., Schmidt, M. K., Ausems, M., Garcia, E. B. G., van de Beek, I., Wevers, M. R., Evans, D Gareth R, Tischkowitz, M., Lalloo, F., Cook, J., Izatt, L., Tripathi, V., Snape, K., Musgrave, H., Sharif, S., Murray, J., Colonna, S. V., Andrulis, I. L., Daly, M. B., Southey, M. C., de la Hoya, M., Osorio, A., Foretova, L., Berkova, D., Gerdes, A. M., Olah, E., Jakubowska, A., Singer, C. F., Tan, Y., Augustinsson, A., Rantala, J., Simard, J., Schmutzler, R. K., Milne, R. L., Phillips, K. A., Terry, M. B., Goldgar, D., van Leeuwen, F. E., Mooij, T. M., Antoniou, A. C., Easton, D. F., Rookus, M. A., Engel, C.
المساهمون: Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
العلاقة: https://dx.doi.org/10.1186/s13058-023-01673-wTest; Kast K, John EM, Hopper JL, Andrieu N, Noguès C, Mouret-Fourme E, et al. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium. Breast cancer research : BCR. 2023 Jun 20;25(1):72. PubMed PMID: 37340476. Pubmed Central PMCID: PMC10280955. Epub 2023/06/21. eng.; http://hdl.handle.net/10541/626379Test; Breast Cancer Research
-
24دورية أكاديمية
المؤلفون: McWilliams, L., Ruane, H., Ulph, F., Woof, V. G., Harrison, F., Evans, D Gareth R, French, David P
المساهمون: Manchester Centre for Health Psychology, Division of Psychology & Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, MAHSC, Oxford Road, M13 9PL, Manchester, UK
العلاقة: https://dx.doi.org/10.1038/s41416-023-02268-0Test; McWilliams L, Ruane H, Ulph F, Woof VG, Harrison F, Evans DG, et al. What do women think about having received their breast cancer risk as part of a risk-stratified NHS Breast Screening Programme? A qualitative study. British journal of cancer. 2023 May 24:1-10. PubMed PMID: 37225893. Pubmed Central PMCID: PMC10206350 AstraZeneca and Everything Genetic. Epub 2023/05/25. eng.; http://hdl.handle.net/10541/626328Test; British Journal of Cancer
-
25دورية أكاديمية
المؤلفون: Flaum, N., Bowes, J., Smith, M. J., Crosbie, E. J., Edmondson, R., Lophatananon, A., Evans, D Gareth R
المساهمون: Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, UK
العلاقة: https://dx.doi.org/10.1016/j.gim.2023.100898Test; Flaum N, Bowes J, Smith MJ, Crosbie EJ, Edmondson R, Lophatananon A, et al. Optimisation of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer. Genetics in medicine : official journal of the American College of Medical Genetics. 2023 May 19:100898. PubMed PMID: 37212253. Epub 2023/05/22. eng.; http://hdl.handle.net/10541/626324Test; Genetics in Medicine
-
26دورية أكاديمية
المؤلفون: Wright, S. J., Eden, M., Ruane, H., Byers, H., Evans, D Gareth R, Harvie, Michelle N, Howell, Sacha J, Howell, Anthony, French, D., Payne, K.
المساهمون: Manchester Centre for Health Economics, Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, The University of Manchester, Manchester, UK
العلاقة: https://dx.doi.org/10.1177/23814683231171363Test; Wright SJ, Eden M, Ruane H, Byers H, Evans DG, Harvie M, et al. Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program. MDM policy & practice. 2023 Jan-Jun;8(1):23814683231171363. PubMed PMID: 37152662. Pubmed Central PMCID: PMC10161319. Epub 2023/05/08. eng.; http://hdl.handle.net/10541/626299Test; MDM Policy and Practice
-
27دورية أكاديمية
المؤلفون: Roberts, E., van Veen, E. M., Byers, H., Barnett-Griness, O., Gronich, N., Lejbkowicz, F., Pinchev, M., Smith, M. J., Howell, Anthony, Newman, W. G., Woodward, E. R., Harkness, E. F., Brentnall, A. R., Cuzick, J., Rennert, G., Howell, Sacha J, Evans, D Gareth R
المساهمون: Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
العلاقة: https://dx.doi.org/10.1016/j.gim.2023.100846Test; Roberts E, van Veen EM, Byers H, Barnett-Griness O, Gronich N, Lejbkowicz F, et al. Article: Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent. Genetics in medicine : official journal of the American College of Medical Genetics. 2023 Apr 12:100846. PubMed PMID: 37061873. Epub 2023/04/17. eng.; http://hdl.handle.net/10541/626232Test; Genetics in Medicine
-
28دورية أكاديمية
المؤلفون: Evans, D Gareth R, McWilliams, L., Astley, S., Brentnall, A. R., Cuzick, J., Dobrashian, R., Duffy, S. W., Gorman, L. S., Harkness, E. F., Harrison, F., Harvie, Michelle N, Jerrison, A., Machin, M., Maxwell, Anthony J, Howell, Sacha J, Wright, S. J., Payne, K., Qureshi, N., Ruane, H., Southworth, J., Fox, L., Bowers, S., Hutchinson, G., Thorpe, E., Ulph, F., Woof, V., Howell, Anthony, French, D. P.
المساهمون: NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, England.
العلاقة: https://dx.doi.org/10.1038/s41416-023-02250-wTest; Gareth Evans D, McWilliams L, Astley S, Brentnall AR, Cuzick J, Dobrashian R, et al. Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420). British journal of cancer. 2023 Apr 1:1-9. PubMed PMID: 37005486. Pubmed Central PMCID: PMC10066938 commercial use of the Tyrer-Cuzick algorithm. All other authors report no competing interests. Epub 2023/04/04. eng.; http://hdl.handle.net/10541/626185Test; British Journal of Cancer
-
29دورية أكاديمية
المؤلفون: Flaum, N., Crosbie, E. J., Woodward, E. R., Lalloo, F., Morgan, Robert David, Ryan, N., Evans, D Gareth R
المساهمون: Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
العلاقة: https://dx.doi.org/10.1136/jmg-2022-109055Test; Flaum N, Crosbie EJ, Woodward ER, Lalloo F, Morgan R, Ryan N, et al. MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1. Journal of medical genetics. 2023 Mar 9. PubMed PMID: 36894311. Epub 2023/03/10. eng.; http://hdl.handle.net/10541/626160Test; Journal of Medical Genetics
-
30دورية أكاديمية
المؤلفون: Harvie, Michelle N, French, David P, Pegington, Mary, Lombardelli, C., Krizak, S., Sellers, K., Barrett, E., Evans, D Gareth R, Cutress, R., Wilding Rgn, A., Graves, L., Howell, Anthony
المساهمون: The Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University NHS Foundation Trust, Manchester, M23 9LT, England
العلاقة: https://dx.doi.org/10.1038/s41416-023-02207-zTest; Harvie M, French DP, Pegington M, Lombardelli C, Krizak S, Sellers K, et al. Randomised controlled trial of breast cancer and multiple disease prevention weight loss programmes vs written advice amongst women attending a breast cancer family history clinic. British journal of cancer. 2023 Feb 25:1-11. PubMed PMID: 36841908. Pubmed Central PMCID: PMC9961304 of an investigator-led Collaborative Research Agreement between SECA GmbH & Co. KG. (Hamburg, Germany), UHS and the University of Southampton. Also institutional research funding by Astra Zeneca (unrelated to this study). The other authors declare no competing interests. Epub 2023/02/26. eng.; http://hdl.handle.net/10541/626089Test; British Journal of Cancer